Show simple item record

Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial

dc.contributor.authorChoueiri, Ten_US
dc.contributor.authorEscudier, Ben_US
dc.contributor.authorPowles, Ten_US
dc.contributor.authorMainwaring, Pen_US
dc.contributor.authorRini, Ben_US
dc.contributor.authorDonskov, Fen_US
dc.contributor.authorHammers, Hen_US
dc.contributor.authorHutson, Ten_US
dc.contributor.authorRoth, Ben_US
dc.contributor.authorPeltola, Ken_US
dc.contributor.authorLee, JLen_US
dc.contributor.authorHeng, Den_US
dc.contributor.authorSchmidinger, Men_US
dc.contributor.authorBorgman-Hagey, Aen_US
dc.contributor.authorHessel, Cen_US
dc.contributor.authorScheffold, Cen_US
dc.contributor.authorSchwab, Gen_US
dc.contributor.authorTannir, Nen_US
dc.contributor.authorMotzer, Ren_US
dc.date.accessioned2016-02-02T15:36:14Z
dc.date.issued2015-09en_US
dc.date.submitted2016-01-13T14:28:17.477Z
dc.identifier.issn0959-8049en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/11011
dc.format.extentS708 - S709en_US
dc.rights• “The final publication is available at http://www.nejm.org/doi/full/10.1056/NEJMoa1510016”
dc.titleCabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trialen_US
dc.typeConference Proceeding
dc.identifier.doi10.1016/S0959-8049(16)31927-Xen_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000361887403250&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume51en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record